Industrial Case Studies Demonstrating Applicability of ICH M7Control Options 3 and 4 for Nitrosamine Control -Pub
|
|
3
|
385
|
March 26, 2025
|
ICH M7 & Nitrosamines Impurities -Updates
|
|
15
|
3508
|
January 20, 2025
|
Synthesis and mutagenic risk of avanafil's potential genotoxic impurities -Pub
|
|
0
|
107
|
August 25, 2024
|
Classification of potentially mutagenic impurities under the ICH M7 guideline -Event
|
|
0
|
392
|
July 23, 2024
|
Leveraging ICH M7 Control Options 3 and 4: Discussion and Clarification Using Industrial Case Studies -Pub
|
|
0
|
545
|
July 23, 2024
|
Non-mutagenic, carcinogenic impurities
|
|
3
|
530
|
June 30, 2024
|